Therapy for Cancer Distress and Quality of Life After Treatment for Advanced Melanoma
Tests talk therapy for cancer-related distress in adults treated for advanced melanoma.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
- Status
- Recruiting
- People taking part
- 350 people, planned
- Started
- 10 Dec 2025
- Expected to end
- 31 Dec 2031
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Best Practice
- Cognitive Behavior Therapy
- Electronic Health Record Review
- Questionnaire Administration
- Record updated
- 22 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with newly diagnosed stage III-IV melanoma. It studies quality of life and mental health after treatment, and whether cognitive behavioral therapy for cancer distress (CBT-C) helps.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Stage III-IV melanoma, diagnosed 2 months ago or less
Main reasons for not taking part
- Not able to read English well enough to complete the survey and informed consent
- Does not meet the inclusion criteria
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Age >= 18-years
- Stage III-IV melanoma and =< 2 month duration of this diagnosis
- Able to read English sufficient to complete survey, informed consent
Who cannot take part
- Does not meet inclusion criteria
Where in United States
- Mayo Clinic in RochesterRochester, United StatesContact: Clinical Trials Referral OfficeTaking people
About the trial
What the trial wants to find out
This clinical trial studies how people feel and live during the first two years after being treated for melanoma and whether cognitive behavioral therapy for cancer distress (CBT-C) works to improve quality of life in patients with stage III-IV melanoma. The melanoma survivorship population is rapidly growing, given the increasing survival rates due to treatment advancements. An urgent need to better define and optimize comprehensive quality of life inclusive of mental health (QOL-MH) has been identified. Cognitive behavioral therapy is a type of psychotherapy that helps patients change their behavior by changing the way they think and feel about certain things. CBT-C is a new type of care that helps patients cope with cancer-related stress, which can include problems like trouble sleeping, trouble focusing, or changes in social life and daily activities. Gathering information on how melanoma patients feel and live during the first two years after treatment may help promote improved care and continued scientific advancements in the understanding of melanoma specific QOL-MH and survivorship as a whole, and may also help determine whether CBT-C improves qualify of life in patients with stage III-IV melanoma.
The 3 groups in the trial
- Aim 1 (QOL-MH)Treatment being tested
Patients complete QOL-MH questionnaires at baseline and 3, 6, 9, 12, 18, and 24-months post-stage III-IV diagnosis. Patients living in Minnesota, Iowa, or Wisconsin may also optionally participate in aim 2.
Treatment: Electronic Health Record Review and Questionnaire Administration
- Aim 2 arm I (CBT-C)Treatment being tested
Patients attend CBT-C sessions once a week for 6 weeks in the absence of unacceptable toxicity.
Treatment: Cognitive Behavior Therapy, Electronic Health Record Review, and Questionnaire Administration
- Aim 2 arm II (SOC)Existing treatment, for comparison
Patients receive SOC for 6 weeks in the absence of unacceptable toxicity.
Treatment: Best Practice, Electronic Health Record Review, and Questionnaire Administration
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Launching the Era of Melanoma Survivorship: Defining Benchmarks in Quality of Life Inclusive of Mental Health (QOL-MH)
- Plain-language title
- Therapy for Cancer Distress and Quality of Life After Treatment for Advanced MelanomaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 22 June 2026